- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotype Standardization for Statin-Induced Myotoxicity
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 96, Issue 4, Pages 470-476
Publisher
Springer Nature
Online
2014-06-04
DOI
10.1038/clpt.2014.121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Electronic health records for biological sample collection: feasibility study of statin-induced myopathy using the Clinical Practice Research Datalink
- (2013) Helen O'Meara et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of a detection algorithm for statin-induced myopathy using electronic medical records
- (2013) K. Sai et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies
- (2013) Payam Mohassel et al. MUSCLE & NERVE
- Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment
- (2013) Louise A. Donnelly et al. Pharmacogenetics and Genomics
- Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis
- (2012) Mark Lemstra et al. CANADIAN JOURNAL OF CARDIOLOGY
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug induced rhabdomyolysis
- (2012) Martin Hohenegger CURRENT OPINION IN PHARMACOLOGY
- The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes
- (2012) Elijah R. Behr et al. EUROPEAN HEART JOURNAL
- Statin induced myotoxicity
- (2012) Sivakumar Sathasivam European Journal of Internal Medicine
- Use of Administrative Data to Estimate the Incidence of Statin-Related Rhabdomyolysis
- (2012) Susan R. Heckbert JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting
- (2012) Mark J. Cziraky et al. Journal of Clinical Lipidology
- Statin Myopathy: A Lipid Clinic Experience on the Tolerability of Statin Rechallenge
- (2011) En C. Fung et al. Cardiovascular Therapeutics
- Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Is there clinical benefit to routine enzyme testing of patients on statins?
- (2011) Asher Elhayany et al. Expert Opinion On Drug Safety
- Characteristics of Drug-Associated Rhabdomyolysis: Analysis of 8,610 Cases Reported to the U.S. Food and Drug Administration
- (2011) Yasuo Oshima INTERNAL MEDICINE
- Managing statin-induced muscle toxicity in a lipid clinic
- (2011) O. Blaier et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cerivastatin, genetic variants, and the risk of rhabdomyolysis
- (2011) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
- (2011) Andrew L. Mammen et al. ARTHRITIS CARE & RESEARCH
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
- (2010) Andrew L. Mammen et al. ARTHRITIS AND RHEUMATISM
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Preempting and preventing drug-induced liver injury
- (2010) Guruprasad P Aithal et al. NATURE GENETICS
- Statin-Associated Muscle-Related Adverse Effects: A Case Series of 354 Patients
- (2010) Stephanie Cham et al. PHARMACOTHERAPY
- Methods for Causality Assessment of Adverse Drug Reactions
- (2009) Taofikat B Agbabiaka et al. DRUG SAFETY
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiretroviral and Statin Drug-Drug Interactions
- (2008) Gretchen M. Ray Cardiology in Review
- Unusual causes of rhabdomyolysis
- (2008) E. E. Mazokopakis INTERNAL MEDICINE JOURNAL
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006
- (2008) Mariam Molokhia et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started